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Synopsis
Outer cortical magnetisation transfer ratio (cMTR) is potentially a sensitive measure of pathology linked to clinical disease progression in
multiple sclerosis (MS). Here we aimed to investigate longitudinal outer and inner cMTR changes in healthy controls (HC) and people with
MS of di�erent clinical subtypes. Follow-up (FU) outer cMTR showed larger reductions in secondary progressive (SP)MS than other
subtypes, and inner cMTR was also reduced more than in HC and relapsing-remitting (RR)MS, although cMTR was reduced in all MS
patients at FU. This supports histopathological �ndings and suggests that cMTR measurement may be relevant to clinical disease
progression in MS.
Purpose
Cortical grey matter (CGM) pathology is common in multiple sclerosis (MS) . Histopathological studies have shown that demyelinating
lesions preferentially form in the outer (subpial) CGM . In some people with secondary progressive (SP)MS neuroaxonal loss is also
greater adjacent to the outer surface of the brain, and it has also been suggested that these abnormalities may be associated with
meningeal in�ammation . Recent in vivo studies have measured the MTR, thought to be sensitive to tissue myelin content , to
investigate abnormalities at di�erent depths in the cortex in healthy controls (HC) and MS . Greater disease e�ects were observed in
outer than inner cortical MTR (cMTR) in people with relapsing-remitting (RR) and SPMS . We have investigated outer and inner cMTR in
di�erent MS clinical subtypes and HC longitudinally, with follow-up (FU) MRI scans performed approximately 2 years after the baseline
(BL) scan.
Methods
Subjects: Ten HC and 51 people with MS were included in this study. Subject demographics are given in Figure 1.
MR acquisition: A 3T Philips Achieva system (Philips Healthcare, Best, The Netherlands) with a 32-channel head coil and multi-transmit
technology was used for scanning. T -weighted (T -w) volumes and MTR data were acquired sagittally, with �eld-of-view
256x256x180mm ; voxel size1x1x1mm . Acquisition parameters are given in Figure 2.
Image Analysis: Each subject’s lesion-�lled  T -w volume was segmented using the Geodesic Informational Flows algorithm . The
normalised central curve of the Laplace equation based cortical thickness map was used to bisect the cortex , taking into account
local curvature and di�erent regional thicknesses. MTR data were a�ne registered to each subject’s T -w volume using NiftyReg , and
a 90% threshold was applied to CGM probability maps to limit potential partial volume e�ects . Inner and outer cortical masks were
applied to calculated MTR maps to obtain mean cortical band MTR values. These processes are illustrated in Figure 3.
Statistical analysis: All statistical analyses were performed using SPSS (IBM SPSS version 22 (SPSS, Inc., Chicago, IL, USA)). Between-group
di�erences in FU MTR values were tested using one-way analysis of covariance (ANCOVA) tests, adjusted for age, gender, Δt, BL MTR and
BL cortical volume. Comparisons between BL and FU MTR for each subgroup were also made using paired t-tests. Between-group
di�erences at both BL and FU in inner and outer mean cMTR were examined using ANCOVA tests, adjusted for age, gender and cortical
volumes.
Results
Examining FU cMTR (adjusting for age, gender, Δt, BL cMTR and BL cortical volume) we found that SPMS outer cMTR was lower than in HC
(p<0.01), primary progressive (PP)MS (p<0.01) and RRMS (p<0.05), and inner cMTR was lower than in HC and RRMS (p<0.05) but not PPMS.
No other signi�cant di�erences between subgroups were seen. Adjusting for relative cortical volume change con�rmed these results
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were not due to atrophy alone.
Comparing subgroup BL to FU: In all patients, outer (p<0.01) and inner cMTR (p=0.001) were reduced at FU. In SPMS, FU outer (p<0.05)
and inner (p=0.001) cMTR were reduced. In PPMS, FU outer cMTR (p<0.05) was lower than at BL, but no signi�cant changes were observed
in RRMS. As expected, no signi�cant di�erences were observed between BL and FU cMTR values in HC.
At BL and FU, the SPMS group had signi�cantly lower outer (p<0.001) and inner (p<0.01) cMTR compared to HC, primary progressive (PP)
MS and RRMS patients had a reduced outer cMTR (p<0.05), and cMTR was reduced in PPMS (p<0.05) but not RRMS (values reported in
Figure 4).
Example HC single slice T -w images and corresponding MTR maps with inner and outer cortical bands superimposed at BL and FU are
shown in Figure 5.
Discussion and Conclusions
The larger cMTR changes observed in SPMS compared to other subgroups is consistent with histopathology studies, and previous MTR
�ndings in vivo .
Reductions in outer cMTR in all patient groups at both points supports previous work and is consistent with histopathological �ndings ,
and supports the inference of a potential role of meningeal in�ammation  contributing to outer cortical pathology.
There was a trend in MTR reduction at FU compared to BL inner and outer cMTR in all subgroups, however signi�cance was only reached
for SPMS outer and inner, and PPMS outer cMTR, and interestingly larger inner cMTR changes were observed in SPMS than in outer cMTR.
This may suggest that later in the disease course pathology is spreading inwards from the outer cortex, and the changes observed could
be relevant to disease progression.
Future studies including larger cohorts of all clinical subtypes would be desirable, and further longitudinal observations are necessary to
determine the dynamics and clinical signi�cance of cMTR abnormalities.
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Figures
Figure 1: Subject Demographics
Components of the MS Functional Composite (MSFC) (nine hole peg test [9HPT], 25 foot timed walk test [TWT] and Paced Auditory Serial
Addition Test [PASAT], expressed as z-scores (Fischer JS et al. Mult Scler. 1999; 5(4):244-50) were determined, calculated using published
normative data.
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Figure 2: Sequence acquisition parameters
Figure 3: Flowchart illustrating image analysis pipeline
Figure 4: Inner and outer cMTR values for all subgroups, at both BL and FU
*p<0.05, **p<0.01, ***p<0.001 compared to controls (at each respective time point), with age, gender and cortical volume included as
covariates (ANCOVA)
Figure 5: Example healthy control subject BL (top) and FU (bottom) single slice T -weighted image and corresponding MTR map (right),
with inner (yellow) and outer (blue) cortical bands superimposed
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